LRRK2 and Parkinson disease: In order to investigate the potential of the 3D-ABSP for NM and iron measurement in PD early disease stages, a sub-cohort of PD patients with <5 years of PD symptoms was analyzed (n = 18; 11 iPD, 7 LRRK2-PD).